Macular Holes: An Action-Oriented Approach

Macular Holes: An Action-Oriented Approach

Join Daniel Epshtein, OD, FAAO, and Steven Ferrucci, OD, FAAO, to review a novel topical therapeutic approach to full-thickness macular holes (FTMHs).

New Content
A Look Back at the Best of 2024 in Ophthalmology
Clinical Guides
A Look Back at the Best of 2024 in Ophthalmology
December 23, 2024
A Look Back at the Best of 2024 in Optometry
Clinical Guides
A Look Back at the Best of 2024 in Optometry
December 23, 2024
The Role of Artificial Intelligence in Retinal Care
Products & Technology
The Role of Artificial Intelligence in Retinal Care
December 20, 2024

Eyes On Eyecare Site Sponsors

Astellas
Lumenis
Recently Published
The Ultimate Guide to XDEMVY® (lotilaner ophthalmic solution) 0.25% for Demodex Blepharitis
PHARMACEUTICALS
The Ultimate Guide to XDEMVY® (lotilaner ophthalmic solution) 0.25% for Demodex Blepharitis

The management paradigm for Demodex blepharitis has shifted dramatically since the FDA approval of XDEMVY (lotilaner 0.25% ophthalmic solution). This guide provides an overview of the condition and a deep dive into this unique treatment modality.

Disclosure: Drs. Zhu and Dierker are paid consultants of Tarsus.

Catching Conversion At Home: Exudative Neovascular AMD
AGE RELATED MACULAR DEGENERATION
Catching Conversion At Home: Exudative Neovascular AMD

Join Daniel Epshtein, OD, FAAO, and Mary Beth Yackey, OD, to review how to monitor patients who convert to exudative neovascular age-related macular degeneration (AMD).

Optimizing Your Influence with Contact Lens Patients
CLINICAL GUIDES
Optimizing Your Influence with Contact Lens Patients

Learn how optometrists can utilize their expertise to individualize care and engage contact lens patients more than online retailers.

Erin Rueff, OD, PhD, FAAODecember 18, 2024
Clinical
A Look Back at the Best of 2024 in Ophthalmology
CLINICAL GUIDES
A Look Back at the Best of 2024 in Ophthalmology

As the year comes to a close, we are taking a look back at some of the most important innovations, relevant trends, and compelling content.

The Role of Artificial Intelligence in Retinal Care
PRODUCTS & TECHNOLOGY
The Role of Artificial Intelligence in Retinal Care

Gain a comprehensive understanding of advancements in artificial intelligence (AI) algorithms for diabetic retinopathy and age-related macular degeneration (AMD).

The Ultimate Guide to XDEMVY® (lotilaner ophthalmic solution) 0.25% for Demodex Blepharitis
PHARMACEUTICALS
The Ultimate Guide to XDEMVY® (lotilaner ophthalmic solution) 0.25% for Demodex Blepharitis

The management paradigm for Demodex blepharitis has shifted dramatically since the FDA approval of XDEMVY (lotilaner 0.25% ophthalmic solution). This guide provides an overview of the condition and a deep dive into this unique treatment modality.

Disclosure: Drs. Zhu and Dierker are paid consultants of Tarsus.

Careers
A Look Back at the Best of 2024 in Optometry
CLINICAL GUIDES
A Look Back at the Best of 2024 in Optometry

As the year comes to a close, we are taking a look back at some of the most important innovations, relevant trends, and compelling content.

An Overview of HPSP from an Optometry Scholarship Recipient
OPTOMETRY STUDENTS
An Overview of HPSP from an Optometry Scholarship Recipient

Gain a comprehensive understanding of what the Health Professions Scholarship Program (HPSP) can offer optometry students.

Arianne Jean-FrançoisDecember 13, 2024
What You Stand to Gain Through Externships In Corporate Settings
EXTERNSHIPS
What You Stand to Gain Through Externships In Corporate Settings

Discover Dr. Ed Shin’s story and experience as an optometry extern working with Dr. Ian Ymalay within the National Vision Doctor of Optometry network.

Sponsored Content
The Ultimate Guide to XDEMVY® (lotilaner ophthalmic solution) 0.25% for Demodex Blepharitis
PHARMACEUTICALS

The Ultimate Guide to XDEMVY® (lotilaner ophthalmic solution) 0.25% for Demodex Blepharitis

The management paradigm for Demodex blepharitis has shifted dramatically since the FDA approval of XDEMVY (lotilaner 0.25% ophthalmic solution). This guide provides an overview of the condition and a deep dive into this unique treatment modality.

Disclosure: Drs. Zhu and Dierker are paid consultants of Tarsus.

Our industry partners

ZEISS
National Vision
EssilorLuxottica
Essilor
Johnson & Johnson Vision
ZEISS Professional Education

Find your next eyecare job

Browse Eyecare Jobs (1,000+)Post a Job

Find your next eyecare job